Slaughter and May advised Reckitt Benckiser Group plc on €1.30 bn dual-tranche issuance

Slaughter and May advised Reckitt Benckiser Group plc ("Reckitt") on the successful pricing and issuance of a €1.30 bn dual-tranche issuance of senior unsecured notes under its £10,000,000,000 Euro Medium Term Note Programme. The transaction represents one of the most significant European capital markets issuances in the consumer goods sector this year.

The offering comprised two tranches of fixed rate notes issued by Reckitt Benckiser Treasury Services plc and guaranteed by Reckitt Benckiser Group plc:

• EUR 650,000,000 3.500 per cent. Fixed Rate Senior Notes due 28 May 2031 issued on 28 May 2026; and 
• EUR 650,000,000 4.000 per cent. Fixed Rate Senior Notes due 28 May 2035 (comprising EUR 500,000,000 Notes issued on 28 May 2026, and a subsequent tap issuance of EUR 150,000,000 Notes issued on 10 June 2026).

The notes are listed on the Main Market of the London Stock Exchange.

Slaughter and May worked closely with Ambika Chauhan (Legal Director, CHQ Functions and Global Sustainability, Group Legal Affairs) throughout.

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in health and hygiene, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet.